dbSNP Short Genetic Variations
Welcome to the Reference SNP (rs) Report
All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.
Reference SNP (rs) Report
This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.
rs1800462
Current Build 157
Released September 3, 2024
- Organism
- Homo sapiens
- Position
-
chr6:18143724 (GRCh38.p14) Help
The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.
- Alleles
- C>G
- Variation Type
- SNV Single Nucleotide Variation
- Frequency
-
G=0.0021522 (3016/1401342, GnomAD_exomes)G=0.002546 (674/264690, TOPMED)G=0.002010 (300/149232, GnomAD_genomes) (+ 13 more)
- Clinical Significance
- Reported in ClinVar
- Gene : Consequence
- TPMT : Missense Variant
- Publications
- 47 citations
- Genomic View
- See rs on genome
ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.
Release Version: 20231103111315
| Population | Group | Sample Size | Ref Allele | Alt Allele | Ref HMOZ | Alt HMOZ | HTRZ | HWEP |
|---|---|---|---|---|---|---|---|---|
| Total | Global | 49258 | C=0.99762 | G=0.00238 | 0.99525 | 0.0 | 0.00475 | 0 |
| European | Sub | 37244 | C=0.99756 | G=0.00244 | 0.995113 | 0.0 | 0.004887 | 0 |
| African | Sub | 3560 | C=0.9997 | G=0.0003 | 0.999438 | 0.0 | 0.000562 | 0 |
| African Others | Sub | 122 | C=1.000 | G=0.000 | 1.0 | 0.0 | 0.0 | N/A |
| African American | Sub | 3438 | C=0.9997 | G=0.0003 | 0.999418 | 0.0 | 0.000582 | 0 |
| Asian | Sub | 168 | C=1.000 | G=0.000 | 1.0 | 0.0 | 0.0 | N/A |
| East Asian | Sub | 112 | C=1.000 | G=0.000 | 1.0 | 0.0 | 0.0 | N/A |
| Other Asian | Sub | 56 | C=1.00 | G=0.00 | 1.0 | 0.0 | 0.0 | N/A |
| Latin American 1 | Sub | 500 | C=0.992 | G=0.008 | 0.984 | 0.0 | 0.016 | 0 |
| Latin American 2 | Sub | 628 | C=0.997 | G=0.003 | 0.993631 | 0.0 | 0.006369 | 0 |
| South Asian | Sub | 98 | C=1.00 | G=0.00 | 1.0 | 0.0 | 0.0 | N/A |
| Other | Sub | 7060 | C=0.9973 | G=0.0027 | 0.994618 | 0.0 | 0.005382 | 0 |
Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").
Download| Study | Population | Group | Sample Size | Ref Allele | Alt Allele |
|---|---|---|---|---|---|
| gnomAD v4 - Exomes | Global | Study-wide | 1401342 | C=0.9978478 | G=0.0021522 |
| gnomAD v4 - Exomes | European | Sub | 1165314 | C=0.9976187 | G=0.0023813 |
| gnomAD v4 - Exomes | South Asian | Sub | 86256 | C=1.00000 | G=0.00000 |
| gnomAD v4 - Exomes | American | Sub | 44722 | C=0.99624 | G=0.00376 |
| gnomAD v4 - Exomes | East Asian | Sub | 39678 | C=1.00000 | G=0.00000 |
| gnomAD v4 - Exomes | African | Sub | 33476 | C=0.99943 | G=0.00057 |
| gnomAD v4 - Exomes | Ashkenazi Jewish | Sub | 26130 | C=0.99801 | G=0.00199 |
| gnomAD v4 - Exomes | Middle Eastern | sub | 5766 | C=0.9997 | G=0.0003 |
| TopMed | Global | Study-wide | 264690 | C=0.997454 | G=0.002546 |
| gnomAD v4 - Genomes | Global | Study-wide | 149232 | C=0.997990 | G=0.002010 |
| gnomAD v4 - Genomes | European | Sub | 78622 | C=0.99796 | G=0.00204 |
| gnomAD v4 - Genomes | African | Sub | 41552 | C=0.99937 | G=0.00063 |
| gnomAD v4 - Genomes | American | Sub | 15274 | C=0.99293 | G=0.00707 |
| gnomAD v4 - Genomes | East Asian | Sub | 5190 | C=0.9998 | G=0.0002 |
| gnomAD v4 - Genomes | South Asian | Sub | 4830 | C=1.0000 | G=0.0000 |
| gnomAD v4 - Genomes | Ashkenazi Jewish | Sub | 3470 | C=0.9986 | G=0.0014 |
| gnomAD v4 - Genomes | Middle Eastern | sub | 294 | C=1.000 | G=0.000 |
| ExAC | Global | Study-wide | 120178 | C=0.998619 | G=0.001381 |
| ExAC | Europe | Sub | 72720 | C=0.99820 | G=0.00180 |
| ExAC | Asian | Sub | 25012 | C=1.00000 | G=0.00000 |
| ExAC | American | Sub | 11458 | C=0.99756 | G=0.00244 |
| ExAC | African | Sub | 10088 | C=0.99950 | G=0.00050 |
| ExAC | Other | Sub | 900 | C=0.998 | G=0.002 |
| The PAGE Study | Global | Study-wide | 78688 | C=0.99793 | G=0.00207 |
| The PAGE Study | AfricanAmerican | Sub | 32510 | C=0.99948 | G=0.00052 |
| The PAGE Study | Mexican | Sub | 10808 | C=0.99685 | G=0.00315 |
| The PAGE Study | Asian | Sub | 8316 | C=0.9999 | G=0.0001 |
| The PAGE Study | PuertoRican | Sub | 7916 | C=0.9957 | G=0.0043 |
| The PAGE Study | NativeHawaiian | Sub | 4534 | C=0.9991 | G=0.0009 |
| The PAGE Study | Cuban | Sub | 4230 | C=0.9950 | G=0.0050 |
| The PAGE Study | Dominican | Sub | 3826 | C=0.9922 | G=0.0078 |
| The PAGE Study | CentralAmerican | Sub | 2450 | C=0.9951 | G=0.0049 |
| The PAGE Study | SouthAmerican | Sub | 1982 | C=0.9975 | G=0.0025 |
| The PAGE Study | NativeAmerican | Sub | 1260 | C=0.9960 | G=0.0040 |
| The PAGE Study | SouthAsian | Sub | 856 | C=1.000 | G=0.000 |
| Allele Frequency Aggregator | Total | Global | 49258 | C=0.99762 | G=0.00238 |
| Allele Frequency Aggregator | European | Sub | 37244 | C=0.99756 | G=0.00244 |
| Allele Frequency Aggregator | Other | Sub | 7060 | C=0.9973 | G=0.0027 |
| Allele Frequency Aggregator | African | Sub | 3560 | C=0.9997 | G=0.0003 |
| Allele Frequency Aggregator | Latin American 2 | Sub | 628 | C=0.997 | G=0.003 |
| Allele Frequency Aggregator | Latin American 1 | Sub | 500 | C=0.992 | G=0.008 |
| Allele Frequency Aggregator | Asian | Sub | 168 | C=1.000 | G=0.000 |
| Allele Frequency Aggregator | South Asian | Sub | 98 | C=1.00 | G=0.00 |
| 1000Genomes_30X | Global | Study-wide | 6404 | C=0.9980 | G=0.0020 |
| 1000Genomes_30X | African | Sub | 1786 | C=0.9994 | G=0.0006 |
| 1000Genomes_30X | Europe | Sub | 1266 | C=0.9953 | G=0.0047 |
| 1000Genomes_30X | South Asian | Sub | 1202 | C=1.0000 | G=0.0000 |
| 1000Genomes_30X | East Asian | Sub | 1170 | C=1.0000 | G=0.0000 |
| 1000Genomes_30X | American | Sub | 980 | C=0.994 | G=0.006 |
| 1000Genomes | Global | Study-wide | 5008 | C=0.9978 | G=0.0022 |
| 1000Genomes | African | Sub | 1322 | C=0.9992 | G=0.0008 |
| 1000Genomes | East Asian | Sub | 1008 | C=1.0000 | G=0.0000 |
| 1000Genomes | Europe | Sub | 1006 | C=0.9940 | G=0.0060 |
| 1000Genomes | South Asian | Sub | 978 | C=1.000 | G=0.000 |
| 1000Genomes | American | Sub | 694 | C=0.994 | G=0.006 |
| Genetic variation in the Estonian population | Estonian | Study-wide | 4480 | C=0.9987 | G=0.0013 |
| The Avon Longitudinal Study of Parents and Children | PARENT AND CHILD COHORT | Study-wide | 3854 | C=0.9984 | G=0.0016 |
| UK 10K study - Twins | TWIN COHORT | Study-wide | 3708 | C=0.9976 | G=0.0024 |
| MxGDAR/Encodat-PGx | Global | Study-wide | 3246 | C=0.9960 | G=0.0040 |
| MxGDAR/Encodat-PGx | MxGDAR | Sub | 3246 | C=0.9960 | G=0.0040 |
| Genome of the Netherlands Release 5 | Genome of the Netherlands | Study-wide | 998 | C=0.999 | G=0.001 |
| Medical Genome Project healthy controls from Spanish population | Spanish controls | Study-wide | 534 | C=0.994 | G=0.006 |
| Qatari | Global | Study-wide | 216 | C=0.995 | G=0.005 |
| The Danish reference pan genome | Danish | Study-wide | 40 | C=0.97 | G=0.03 |
Help
Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.
Genomic Placements
| Sequence name | Change |
|---|---|
| GRCh38.p14 chr 6 | NC_000006.12:g.18143724C>G |
| GRCh37.p13 chr 6 | NC_000006.11:g.18143955C>G |
| TPMT RefSeqGene (LRG_874) | NG_012137.3:g.16420G>C |
Gene: TPMT, thiopurine S-methyltransferase
(minus strand)
| Molecule type | Change | Amino acid[Codon] | SO Term |
|---|---|---|---|
| TPMT transcript variant 2 | NM_001346817.1:c.238G>C | A [GCA] > P [CCA] | Coding Sequence Variant |
| thiopurine S-methyltransferase isoform 1 | NP_001333746.1:p.Ala80Pro | A (Ala) > P (Pro) | Missense Variant |
| TPMT transcript variant 3 | NM_001346818.1:c.238G>C | A [GCA] > P [CCA] | Coding Sequence Variant |
| thiopurine S-methyltransferase isoform 2 | NP_001333747.1:p.Ala80Pro | A (Ala) > P (Pro) | Missense Variant |
| TPMT transcript variant 1 | NM_000367.5:c.238G>C | A [GCA] > P [CCA] | Coding Sequence Variant |
| thiopurine S-methyltransferase isoform 1 | NP_000358.1:p.Ala80Pro | A (Ala) > P (Pro) | Missense Variant |
| TPMT transcript variant X1 | XM_047419289.1:c.238G>C | A [GCA] > P [CCA] | Coding Sequence Variant |
| thiopurine S-methyltransferase isoform X1 | XP_047275245.1:p.Ala80Pro | A (Ala) > P (Pro) | Missense Variant |
| TPMT transcript variant X2 | XM_047419290.1:c.238G>C | A [GCA] > P [CCA] | Coding Sequence Variant |
| thiopurine S-methyltransferase isoform X2 | XP_047275246.1:p.Ala80Pro | A (Ala) > P (Pro) | Missense Variant |
Help
Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.
Allele: G (allele ID:
27760
)
| ClinVar Accession | Disease Names | Clinical Significance |
|---|---|---|
| RCV000013558.12 | Thiopurine S-methyltransferase deficiency | Drug-Response |
Help
Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".
| Placement | C= | G |
|---|---|---|
| GRCh38.p14 chr 6 | NC_000006.12:g.18143724= | NC_000006.12:g.18143724C>G |
| GRCh37.p13 chr 6 | NC_000006.11:g.18143955= | NC_000006.11:g.18143955C>G |
| TPMT RefSeqGene (LRG_874) | NG_012137.3:g.16420= | NG_012137.3:g.16420G>C |
| TPMT transcript variant 1 | NM_000367.5:c.238= | NM_000367.5:c.238G>C |
| TPMT transcript variant 1 | NM_000367.4:c.238= | NM_000367.4:c.238G>C |
| TPMT transcript | NM_000367.3:c.238= | NM_000367.3:c.238G>C |
| TPMT transcript | NM_000367.2:c.238= | NM_000367.2:c.238G>C |
| TPMT transcript variant 2 | NM_001346817.1:c.238= | NM_001346817.1:c.238G>C |
| TPMT transcript variant 3 | NM_001346818.1:c.238= | NM_001346818.1:c.238G>C |
| TPMT transcript variant X1 | XM_047419289.1:c.238= | XM_047419289.1:c.238G>C |
| TPMT transcript variant X2 | XM_047419290.1:c.238= | XM_047419290.1:c.238G>C |
| thiopurine S-methyltransferase isoform 1 | NP_000358.1:p.Ala80= | NP_000358.1:p.Ala80Pro |
| thiopurine S-methyltransferase isoform 1 | NP_001333746.1:p.Ala80= | NP_001333746.1:p.Ala80Pro |
| thiopurine S-methyltransferase isoform 2 | NP_001333747.1:p.Ala80= | NP_001333747.1:p.Ala80Pro |
| thiopurine S-methyltransferase isoform X1 | XP_047275245.1:p.Ala80= | XP_047275245.1:p.Ala80Pro |
| thiopurine S-methyltransferase isoform X2 | XP_047275246.1:p.Ala80= | XP_047275246.1:p.Ala80Pro |
Help
Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.
65 SubSNP,
16 Frequency,
1 ClinVar
submissions
| No | Submitter | Submission ID | Date (Build) |
|---|---|---|---|
| 1 | HGBASE | ss2420556 | Nov 14, 2000 (89) |
| 2 | CGM_KYOTO | ss76875475 | Dec 06, 2007 (129) |
| 3 | BCM-HGSC-SUB | ss207734448 | Jul 04, 2010 (132) |
| 4 | OMICIA | ss244238583 | Aug 29, 2012 (137) |
| 5 | OMIM-CURATED-RECORDS | ss275515907 | Nov 29, 2010 (133) |
| 6 | NHLBI-ESP | ss342202130 | May 09, 2011 (134) |
| 7 | 1000GENOMES | ss458700776 | Sep 17, 2011 (135) |
| 8 | 1000GENOMES | ss490920231 | May 04, 2012 (137) |
| 9 | EXOME_CHIP | ss491378166 | May 04, 2012 (137) |
| 10 | CLINSEQ_SNP | ss491881239 | May 04, 2012 (137) |
| 11 | ILLUMINA | ss780845876 | Aug 21, 2014 (142) |
| 12 | ILLUMINA | ss783529423 | Aug 21, 2014 (142) |
| 13 | EVA-GONL | ss982638345 | Aug 21, 2014 (142) |
| 14 | 1000GENOMES | ss1319172910 | Aug 21, 2014 (142) |
| 15 | EVA_GENOME_DK | ss1581553331 | Apr 01, 2015 (144) |
| 16 | EVA_DECODE | ss1592188721 | Apr 01, 2015 (144) |
| 17 | EVA_UK10K_ALSPAC | ss1615060673 | Apr 01, 2015 (144) |
| 18 | EVA_UK10K_TWINSUK | ss1658054706 | Apr 01, 2015 (144) |
| 19 | EVA_EXAC | ss1688172487 | Apr 01, 2015 (144) |
| 20 | EVA_MGP | ss1711113296 | Apr 01, 2015 (144) |
| 21 | ILLUMINA | ss1752617971 | Sep 08, 2015 (146) |
| 22 | ILLUMINA | ss1917799672 | Feb 12, 2016 (147) |
| 23 | WEILL_CORNELL_DGM | ss1925894498 | Feb 12, 2016 (147) |
| 24 | ILLUMINA | ss1946168683 | Feb 12, 2016 (147) |
| 25 | ILLUMINA | ss1958867474 | Feb 12, 2016 (147) |
| 26 | HUMAN_LONGEVITY | ss2282198733 | Dec 20, 2016 (150) |
| 27 | GNOMAD | ss2735561655 | Nov 08, 2017 (151) |
| 28 | GNOMAD | ss2747554118 | Nov 08, 2017 (151) |
| 29 | GNOMAD | ss2836354025 | Nov 08, 2017 (151) |
| 30 | AFFY | ss2985355007 | Nov 08, 2017 (151) |
| 31 | AFFY | ss2985984217 | Nov 08, 2017 (151) |
| 32 | SWEGEN | ss2998599312 | Nov 08, 2017 (151) |
| 33 | ILLUMINA | ss3022579722 | Nov 08, 2017 (151) |
| 34 | ILLUMINA | ss3629456213 | Oct 12, 2018 (152) |
| 35 | ILLUMINA | ss3635046810 | Oct 12, 2018 (152) |
| 36 | ILLUMINA | ss3640754106 | Oct 12, 2018 (152) |
| 37 | ILLUMINA | ss3644901746 | Oct 12, 2018 (152) |
| 38 | ILLUMINA | ss3653088337 | Oct 12, 2018 (152) |
| 39 | ILLUMINA | ss3654123239 | Oct 12, 2018 (152) |
| 40 | EGCUT_WGS | ss3666529135 | Jul 13, 2019 (153) |
| 41 | EVA_DECODE | ss3716687399 | Jul 13, 2019 (153) |
| 42 | ILLUMINA | ss3726314886 | Jul 13, 2019 (153) |
| 43 | ILLUMINA | ss3744546301 | Jul 13, 2019 (153) |
| 44 | ILLUMINA | ss3745346896 | Jul 13, 2019 (153) |
| 45 | PAGE_CC | ss3771266120 | Jul 13, 2019 (153) |
| 46 | ILLUMINA | ss3772840684 | Jul 13, 2019 (153) |
| 47 | EVA | ss3824158501 | Apr 26, 2020 (154) |
| 48 | EVA | ss3825690607 | Apr 26, 2020 (154) |
| 49 | EVA | ss3984448415 | Apr 26, 2021 (155) |
| 50 | EVA | ss3986337297 | Apr 26, 2021 (155) |
| 51 | TOPMED | ss4695327273 | Apr 26, 2021 (155) |
| 52 | EVA | ss6234523216 | Nov 02, 2024 (157) |
| 53 | EVA | ss6297654078 | Nov 02, 2024 (157) |
| 54 | EVA | ss6349657877 | Nov 02, 2024 (157) |
| 55 | GNOMAD | ss6426752156 | Nov 02, 2024 (157) |
| 56 | GNOMAD | ss6707994729 | Nov 02, 2024 (157) |
| 57 | 1000G_HIGH_COVERAGE | ss8267581496 | Nov 02, 2024 (157) |
| 58 | EVA | ss8364131430 | Nov 02, 2024 (157) |
| 59 | HUGCELL_USP | ss8465357356 | Nov 02, 2024 (157) |
| 60 | EVA | ss8512473850 | Nov 02, 2024 (157) |
| 61 | 1000G_HIGH_COVERAGE | ss8553087414 | Nov 02, 2024 (157) |
| 62 | SANFORD_IMAGENETICS | ss8639870511 | Nov 02, 2024 (157) |
| 63 | EVA | ss8848082790 | Nov 02, 2024 (157) |
| 64 | EVA | ss8882861039 | Nov 02, 2024 (157) |
| 65 | EVA | ss8968372878 | Nov 02, 2024 (157) |
| 66 | 1000Genomes | NC_000006.11 - 18143955 | Oct 12, 2018 (152) |
| 67 | 1000Genomes_30X | NC_000006.12 - 18143724 | Nov 02, 2024 (157) |
| 68 | The Avon Longitudinal Study of Parents and Children | NC_000006.11 - 18143955 | Oct 12, 2018 (152) |
| 69 | Genetic variation in the Estonian population | NC_000006.11 - 18143955 | Oct 12, 2018 (152) |
| 70 | ExAC | NC_000006.11 - 18143955 | Oct 12, 2018 (152) |
| 71 | The Danish reference pan genome | NC_000006.11 - 18143955 | Apr 26, 2020 (154) |
| 72 | gnomAD v4 - Exomes | NC_000006.12 - 18143724 | Nov 02, 2024 (157) |
| 73 | gnomAD v4 - Genomes | NC_000006.12 - 18143724 | Nov 02, 2024 (157) |
| 74 | Genome of the Netherlands Release 5 | NC_000006.11 - 18143955 | Apr 26, 2020 (154) |
| 75 | Medical Genome Project healthy controls from Spanish population | NC_000006.11 - 18143955 | Apr 26, 2020 (154) |
| 76 | The PAGE Study | NC_000006.12 - 18143724 | Jul 13, 2019 (153) |
| 77 | MxGDAR/Encodat-PGx | NC_000006.11 - 18143955 | Apr 26, 2021 (155) |
| 78 | Qatari | NC_000006.11 - 18143955 | Apr 26, 2020 (154) |
| 79 | TopMed | NC_000006.12 - 18143724 | Apr 26, 2021 (155) |
| 80 | UK 10K study - Twins | NC_000006.11 - 18143955 | Oct 12, 2018 (152) |
| 81 | ALFA | NC_000006.12 - 18143724 | Nov 02, 2024 (157) |
| 82 | ClinVar | RCV000013558.12 | Nov 02, 2024 (157) |
Help
History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).
Added to this RefSNP Cluster:
| Submission IDs | Observation SPDI | Canonical SPDI | Source RSIDs |
|---|---|---|---|
| ss207734448, ss491881239, ss1592188721 | NC_000006.10:18251933:C:G | NC_000006.12:18143723:C:G | (self) |
| 30924005, 17225344, 12267383, 8192500, 7718270, 7641785, 229056, 1416, 7936428, 17225344, ss342202130, ss458700776, ss490920231, ss491378166, ss780845876, ss783529423, ss982638345, ss1319172910, ss1581553331, ss1615060673, ss1658054706, ss1688172487, ss1711113296, ss1752617971, ss1917799672, ss1925894498, ss1946168683, ss1958867474, ss2735561655, ss2747554118, ss2836354025, ss2985355007, ss2985984217, ss2998599312, ss3022579722, ss3629456213, ss3635046810, ss3640754106, ss3644901746, ss3653088337, ss3654123239, ss3666529135, ss3744546301, ss3745346896, ss3772840684, ss3824158501, ss3825690607, ss3984448415, ss3986337297, ss6234523216, ss6297654078, ss6349657877, ss8364131430, ss8512473850, ss8639870511, ss8848082790, ss8968372878 | NC_000006.11:18143954:C:G | NC_000006.12:18143723:C:G | (self) |
| RCV000013558.12, 40613349, 22063103, 234764292, 487589, 532704831, 9093938368, ss244238583, ss275515907, ss2282198733, ss3716687399, ss3726314886, ss3771266120, ss4695327273, ss6426752156, ss6707994729, ss8267581496, ss8465357356, ss8553087414, ss8882861039 | NC_000006.12:18143723:C:G | NC_000006.12:18143723:C:G | (self) |
| ss2420556, ss76875475 | NT_007592.15:18083954:C:G | NC_000006.12:18143723:C:G | (self) |
Help
Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.
47
citations for rs1800462
| PMID | Title | Author | Year | Journal |
|---|---|---|---|---|
| 1960624 | Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia. | Evans WE et al. | 1991 | The Journal of pediatrics |
| 7862671 | A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase. | Krynetski EY et al. | 1995 | Proceedings of the National Academy of Sciences of the United States of America |
| 8644731 | Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians. | Tai HL et al. | 1996 | American journal of human genetics |
| 9177237 | Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): mechanisms for the genetic polymorphism of TPMT activity. | Tai HL et al. | 1997 | Proceedings of the National Academy of Sciences of the United States of America |
| 9931345 | Thiopurine methyltransferase alleles in British and Ghanaian populations. | Ameyaw MM et al. | 1999 | Human molecular genetics |
| 18547414 | Genotyping panel for assessing response to cancer chemotherapy. | Dai Z et al. | 2008 | BMC medical genomics |
| 18685564 | Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia. | Stocco G et al. | 2009 | Clinical pharmacology and therapeutics |
| 20855458 | Ecto-5'-nucleotidase and thiopurine cellular circulation: association with cytotoxicity. | Li F et al. | 2010 | Drug metabolism and disposition |
| 21395650 | Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy. | Adam de Beaumais T et al. | 2011 | British journal of clinical pharmacology |
| 22385887 | High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease. | Larussa T et al. | 2012 | European journal of internal medicine |
| 22871999 | Concordance of DMET plus genotyping results with those of orthogonal genotyping methods. | Fernandez CA et al. | 2012 | Clinical pharmacology and therapeutics |
| 23133420 | Pharmacogenomic Diversity among Brazilians: Influence of Ancestry, Self-Reported Color, and Geographical Origin. | Suarez-Kurtz G et al. | 2012 | Frontiers in pharmacology |
| 23335936 | Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia. | Stocco G et al. | 2012 | Frontiers in genetics |
| 24232128 | Genotype and allele frequencies of drug-metabolizing enzymes and drug transporter genes affecting immunosuppressants in the Spanish white population. | Bosó V et al. | 2014 | Therapeutic drug monitoring |
| 24762746 | New genetic biomarkers predicting azathioprine blood concentrations in combination therapy with 5-aminosalicylic acid. | Uchiyama K et al. | 2014 | PloS one |
| 24860591 | Imputation of TPMT defective alleles for the identification of patients with high-risk phenotypes. | Almoguera B et al. | 2014 | Frontiers in genetics |
| 24944790 | Screening for 392 polymorphisms in 141 pharmacogenes. | Kim JY et al. | 2014 | Biomedical reports |
| 25419701 | Exploring the distribution of genetic markers of pharmacogenomics relevance in Brazilian and Mexican populations. | Bonifaz-Peña V et al. | 2014 | PloS one |
| 25741362 | Use of pharmacogenomics in pediatric renal transplant recipients. | Medeiros M et al. | 2015 | Frontiers in genetics |
| 26878724 | NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity. | Moriyama T et al. | 2016 | Nature genetics |
| 27294413 | Human genome meeting 2016 : Houston, TX, USA. 28 February - 2 March 2016. | Srivastava AK et al. | 2016 | Human genomics |
| 27307154 | A Simple Method for TPMT and ITPA Genotyping Using Multiplex HRMA for Patients Treated with Thiopurine Drugs. | Skrzypczak-Zielinska M et al. | 2016 | Molecular diagnosis & therapy |
| 27564568 | Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic Trait. | Liu C et al. | 2017 | Clinical pharmacology and therapeutics |
| 27618021 | Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical Use. | Mlakar V et al. | 2016 | International journal of molecular sciences |
| 27636550 | A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics. | Mizzi C et al. | 2016 | PloS one |
| 28462921 | One amino acid makes a difference-Characterization of a new TPMT allele and the influence of SAM on TPMT stability. | Iu YPH et al. | 2017 | Scientific reports |
| 28476189 | Analysis of Thiopurine S-Methyltransferase Deficient Alleles in Acute Lymphoblastic Leukemia Patients in Mexican Patients. | Jiménez-Morales S et al. | 2016 | Archives of medical research |
| 29193749 | Clinical Implementation of Pharmacogenetic Testing in a Hospital of the Spanish National Health System: Strategy and Experience Over 3 Years. | Borobia AM et al. | 2018 | Clinical and translational science |
| 29264794 | High frequency of mutant thiopurine S-methyltransferase genotypes in Mexican patients with systemic lupus erythematosus and rheumatoid arthritis. | Ramirez-Florencio M et al. | 2018 | Clinical rheumatology |
| 29373914 | Genetic Polymorphism of Thiopurine S-methyltransferase in Children with Acute Lymphoblastic Leukemia in Jordan. | Alsous M et al. | 2018 | Asian Pacific journal of cancer prevention |
| 30987408 | Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants. | Lucafò M et al. | 2019 | Genes |
| 31019283 | Secondary actionable findings identified by exome sequencing: expected impact on the organisation of care from the study of 700 consecutive tests. | Thauvin-Robinet C et al. | 2019 | European journal of human genetics |
| 31446180 | Genotype-based Treatment With Thiopurine Reduces Incidence of Myelosuppression in Patients With Inflammatory Bowel Diseases. | Chang JY et al. | 2020 | Clinical gastroenterology and hepatology |
| 31507415 | ITPA, TPMT, and NUDT15 Genetic Polymorphisms Predict 6-Mercaptopurine Toxicity in Middle Eastern Children With Acute Lymphoblastic Leukemia. | Moradveisi B et al. | 2019 | Frontiers in pharmacology |
| 32213001 | UEG Week 2019 Poster Presentations. | 2019 | United European gastroenterology journal | |
| 32326111 | Role of Genetic Variations in the Hepatic Handling of Drugs. | Marin JJG et al. | 2020 | International journal of molecular sciences |
| 32453263 | Pharmacogenomics of thiopurines: distribution of TPMT and NUDT15 polymorphisms in the Brazilian Amazon. | Ferreira GMA et al. | 2020 | Pharmacogenetics and genomics |
| 32704308 | Thiopurine S-methyltransferase genetic polymorphisms in adult patients with inflammatory bowel diseases in the Latvian population. | Zalizko P et al. | 2020 | Therapeutic advances in gastroenterology |
| 33348915 | PharmFrag: An Easy and Fast Multiplex Pharmacogenetics Assay to Simultaneously Analyze 9 Genetic Polymorphisms Involved in Response Variability of Anticancer Drugs. | Bouvet R et al. | 2020 | International journal of molecular sciences |
| 33519226 | Genetic Diversity of Drug-Related Genes in Native Americans of the Brazilian Amazon. | Fernandes MR et al. | 2021 | Pharmacogenomics and personalized medicine |
| 34385834 | Individualized Drugs' Selection by Evaluation of Drug Properties, Pharmacogenomics and Clinical Parameters: Performance of a Bioinformatic Tool Compared to a Clinically Established Counselling Process. | Borro M et al. | 2021 | Pharmacogenomics and personalized medicine |
| 34412101 | Comprehensive characterization of pharmacogenetic variants in TPMT and NUDT15 in children with acute lymphoblastic leukemia. | Moriyama T et al. | 2022 | Pharmacogenetics and genomics |
| 34621706 | Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platform. | Kim B et al. | 2021 | Translational and clinical pharmacology |
| 34629890 | NUDT15 c.415C>T Polymorphism Predicts 6-MP Induced Early Myelotoxicity in Patients with Acute Lymphoblastic Leukemia Undergoing Maintenance Therapy. | Pai AA et al. | 2021 | Pharmacogenomics and personalized medicine |
| 35089958 | Identification of pharmacogenetic variants from large scale next generation sequencing data in the Saudi population. | Goljan E et al. | 2022 | PloS one |
| 35431360 | Susceptibility to thiopurine toxicity by TPMT and NUDT15 variants in Colombian children with acute lymphoblastic leukemia. | Correa-Jimenez O et al. | 2021 | Colombia medica (Cali, Colombia) |
| 36164570 | Prevalence of exposure to pharmacogenetic drugs by the Saudis treated at the health care centers of the Ministry of National Guard. | Alshabeeb MA et al. | 2022 | Saudi pharmaceutical journal |
Help
The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.
Genome context:
Select flank length:
Genomic regions, transcripts, and products
Top▲
Help
NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.
NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.